BRISTOL MYERS SQUIBB
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1989-01-01
- Employees
- 30K
- Market Cap
- $97.5B
- Website
- https://www.bms.com/
Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB)
- Conditions
- Staphylococcus Aureus Bacteremia
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2013-03-29
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 60
- Registration Number
- NCT00198302
An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection
- Conditions
- HIV Infection
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2014-01-09
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00162227
- Locations
- 🇺🇸
Children'S Hospital, Boston, Massachusetts, United States
🇺🇸State University Of New York At Stony Brook, Stony Brook, New York, United States
🇺🇸Metro Health Medical Center, Cleveland, Ohio, United States
Abatacept With Methotrexate- Phase IIB
- Conditions
- Rheumatoid Arthritis
- Interventions
- Drug: Placebo
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2012-06-01
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 524
- Registration Number
- NCT00162266
- Locations
- 🇬🇧
Local Institution, Leeds, Yorkshire, United Kingdom
Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 33
- Registration Number
- NCT00162292
- Locations
- 🇲🇽
Local Institution, Leon, Guanajuato, Mexico
🇺🇸Delray Research Associates, Delray Beach, Florida, United States
🇺🇸Phase Iii Clinical Research, Fall River, Massachusetts, United States
Study of BMS-587101 in Patients With Moderate to Severe Psoriasis
- Conditions
- Psoriasis, Moderate to Severe
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 120
- Registration Number
- NCT00162253
- Locations
- 🇺🇸
Local Institution, Dallas, Texas, United States
The Study of Abatacept in Combination With Etanercept
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2010-12-06
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 141
- Registration Number
- NCT00162279
- Locations
- 🇺🇸
Local Institution, Glendale, Wisconsin, United States
Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment
- Conditions
- HIV InfectionsHepatic Impairment
- Interventions
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2010-09-14
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 21
- Registration Number
- NCT00162097
- Locations
- 🇮🇹
Local Institution, Milano, Italy
🇺🇸Uthscsa, San Antonio, Texas, United States
🇺🇸Johns Hopkins University School Of Medicine, Baltimore, Maryland, United States
Study of Dasatinib in Patients With Advanced Solid Tumors
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2011-04-14
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 60
- Registration Number
- NCT00162214
- Locations
- 🇺🇸
Lee S. Rosen M.D., Santa Monica, California, United States
🇺🇸H. Lee Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸Md Anderson Cancer Center, Houston, Texas, United States
PPAR-COMBO With Sulfonylurea
- Conditions
- Metabolics Diabetes Nos
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2010-09-14
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 534
- Registration Number
- NCT00162175
- Locations
- 🇬🇧
Local Institution, Swan Lane, United Kingdom
An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada
- Conditions
- HIV Infection
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2014-01-09
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00162188
- Locations
- 🇨🇦
Local Institution, Montreal, Quebec, Canada